Persistent Asset Partners LTD Ascendis Pharma A/S Transaction History
Persistent Asset Partners LTD
- $119 Billion
- Q1 2025
A detailed history of Persistent Asset Partners LTD transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Persistent Asset Partners LTD holds 1,906 shares of ASND stock, worth $338,410. This represents 0.25% of its overall portfolio holdings.
Number of Shares
1,906
Previous 8,940
78.68%
Holding current value
$338,410
Previous $1.17 Billion
74.57%
% of portfolio
0.25%
Previous 0.97%
Shares
2 transactions
Others Institutions Holding ASND
# of Institutions
270Shares Held
61.9MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.83 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$973 Million4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$926 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$797 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$756 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $9.91B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...